Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt-Jakob disease-based deferral?

被引:0
|
作者
Hirani, Rena [1 ,2 ,6 ]
Hoad, Veronica C. [3 ]
Gosbell, Iain B. [1 ,4 ]
Irving, David O. [1 ,5 ]
机构
[1] Australian Red Cross Lifeblood, Sydney, Australia
[2] Macquarie Univ, Sch Nat Sci, Sydney, Australia
[3] Australian Red Cross Lifeblood, Perth, Australia
[4] Western Sydney Univ, Sch Med, Sydney, Australia
[5] Univ Technol, Fac Hlth, Sydney, Australia
[6] Australian Red Cross Lifeblood, Res & Dev, 17 ORiordan St, Sydney, NSW, Australia
关键词
Australia; blood donation deferral; blood donor; blood groups; UK; variant Creutzfeldt-Jakob disease;
D O I
10.1111/vox.13614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Until 25 July 2022, Australians who had spent more than 6 months in the United Kingdom or territories between 1980 and 1996 were deferred from blood donation due to the risk of variant Creutzfeldt-Jakob disease. Removal of this geography-based donor deferral on RhD-negative blood availability has not been reported. Materials and Methods: All donors who donated at least once from 25 July 2022 to 25 July 2023 were included. UK donor status, first-time donor and ABO RhD data were extracted from the National Blood Management System. Results: Data from 566,447 blood donors with a valid ABO RhD result were analysed. Of these, 34,560 were new or returning lapsed donors following removal of the UK donor deferral. The median age [range] in years for all donors was 43 [75] with UK donors being older 53 [70]. There was a higher prevalence of RhD-negative status in UK donors (20.2%) compared with first-time blood donors (15.7%). Conclusion: UK donors were generally older, female and more likely to be RhD-negative. Although UK donors provided a boost to RhD-negative blood collections, the overall prevalence of ABO RhD blood groups in the total Australian blood donor panel remained similar to previous estimates.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 15 条
  • [1] Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies
    Correll, PK
    Law, MG
    Seed, CR
    Gust, A
    Buring, M
    Dax, EM
    Keller, AJ
    Kaldor, JM
    VOX SANGUINIS, 2001, 81 (01) : 6 - 11
  • [2] Impact of deferral criteria on prevention of Creutzfeldt-Jakob disease and its variant among blood donors in Sao Paulo, Brazil
    Neto, CA
    Mendrone, A
    Vieira, A
    Dorlhiac-Llacer, PE
    Chamone, DA
    TRANSFUSION, 2005, 45 (03) : 102A - 102A
  • [3] Risk of variant Creutzfeldt-Jakob disease in a simulated cohort of Canadian blood donors
    di Borgo, Alexis Pozzo
    Germain, Marc
    O'Brien, Sheila F.
    Delage, Gilles
    Renaud, Christian
    Lewin, Antoine
    VOX SANGUINIS, 2023, 118 (09) : 738 - 745
  • [4] Exclusion of blood donors at risk for the variant Creutzfeldt-Jakob Disease in a Spanish community.
    Mascaro, M
    Sedenyo, M
    Jimenez, T
    Girona, E
    Muncunill, J
    TRANSFUSION, 2002, 42 (09) : 89S - 89S
  • [5] Blood donor notification of variant Creutzfeldt-Jakob disease risk: Lessons in communicating donor deferral and risk
    Reynolds, Claire A.
    Yawitch, Tali
    Hewitt, Patricia E.
    Harvala, Heli
    TRANSFUSION MEDICINE, 2023, 33 (01) : 75 - 80
  • [6] Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay
    Edgeworth, Julie Ann
    Farmer, Michael
    Sicilia, Anita
    Tavares, Paul
    Beck, Jonathan
    Campbell, Tracy
    Lowe, Jessica
    Mead, Simon
    Rudge, Peter
    Collinge, John
    Jackson, Graham S.
    LANCET, 2011, 377 (9764): : 487 - 493
  • [7] Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies
    Yang, Hong
    Huang, Yin
    Gregori, Luisa
    Asher, David M.
    Bui, Travis
    Forshee, Richard A.
    Anderson, Steven A.
    TRANSFUSION, 2017, 57 (04) : 924 - 932
  • [8] Modeling the implications of whole blood versus double red cell collection and European travel deferral for variant Creutzfeldt-Jakob Disease
    Madden, E.
    Murphy, E. L.
    Custer, B.
    TRANSFUSION, 2006, 46 (09) : 188A - 188A
  • [9] Geographic risk of variant Creutzfeldt-Jakob disease: A risk ranking model to evaluate options for blood donor deferral policies in the US
    Yang, Hong
    Huang, Yin
    Bui-Klimke, Travis
    Gregori, Luisa
    Asher, David M.
    Forshee, Richard A.
    Anderson, Steven A.
    PRION, 2016, 10 : S101 - S102
  • [10] Investigating Enthusiasm for a "Donate Blood for Research" Program among Australian-Deferred Blood Donors: Examining the Attitudes of a Sample of Variant Creutzfeldt-Jakob Disease (vCJD) Risk Deferred Donors
    Waller, D.
    Garradd, A.
    Cheah, S.
    TRANSFUSION, 2013, 53 : 103A - 103A